BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33264786)

  • 1. Early Cytokine Removal in Critical COVID-19 Patients with Extracorporeal Therapies (HA-380 plus High Volume Hemofiltration) May Prevent Progression of Acute Respiratory Distress Syndrome: Case Report.
    Ramírez-Guerrero G; Torres Cifuentes V; Baghetti Hernández R; Villagrán Cortés F; Rojas Doll S; Oliva Alarcón R; Lucero Córdova C; Flores Fernandez P; Garay Coloma O
    Blood Purif; 2021; 50(4-5):575-577. PubMed ID: 33264786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia.
    Rampino T; Gregorini M; Perotti L; Ferrari F; Pattonieri EF; Grignano MA; Valente M; Garrone A; Islam T; Libetta C; Sepe V; Albertini R; Bruno R; Belliato M
    Blood Purif; 2021; 50(4-5):566-571. PubMed ID: 33181508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19.
    Esmaeili Vardanjani A; Ronco C; Rafiei H; Golitaleb M; Pishvaei MH; Mohammadi M
    Blood Purif; 2021; 50(2):257-260. PubMed ID: 32594085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoperfusion as a Potential Treatment for Critically Ill COVID-19 Patients with Cytokine Storm.
    Shadvar K; Tagizadiyeh A; Gamari AA; Soleimanpour H; Mahmoodpoor A
    Blood Purif; 2021; 50(3):405-407. PubMed ID: 33171470
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokine Blood Filtration Responses in COVID-19.
    Al Shareef K; Bakouri M
    Blood Purif; 2021; 50(2):141-149. PubMed ID: 32464624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous venous hemodialysis integrated to the ECMO circuit in critically ill patient with COVID-19, a case report in Morocco.
    Mounir A; Lamghari S; Raja A; Allali K; Chebbar S; Buri B; Mahdar Y; Kettani CE; Ramdani B; Ettaoumi Y; Benouna G; Barrou L
    Pan Afr Med J; 2020; 35(Suppl 2):141. PubMed ID: 33193956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic plasma exchange in a critically ill Covid-19 patient.
    Altmayer V; Saheb S; Rohaut B; Marois C; Cao A; Gallo A; Le Guennec L; Weiss N; Demeret S
    J Clin Apher; 2021 Feb; 36(1):179-182. PubMed ID: 32875601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the Cytokine Adsorption Therapy in Patients with Severe COVID-19-Associated Pneumonia: Lesson Learned from a Prospective Observational Study.
    Kusirisin P; Noppakun K; Trongtrakul K; Vongsanim S; Suteeka Y; Ophascharoensuk V; Pongsuwan K; Narongkiatikhun P; Theerakittikul T; Apaijai N; Chattipakorn SC; Chattipakorn N; Srisawat N
    Blood Purif; 2024; 53(1):10-22. PubMed ID: 37918373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe COVID-19 Infections-Knowledge Gained and Remaining Questions.
    Bos LDJ; Brodie D; Calfee CS
    JAMA Intern Med; 2021 Jan; 181(1):9-11. PubMed ID: 32945833
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report.
    Faqihi F; Alharthy A; Alshaya R; Papanikolaou J; Kutsogiannis DJ; Brindley PG; Karakitsos D
    BMC Cardiovasc Disord; 2020 Aug; 20(1):389. PubMed ID: 32842957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
    Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D
    Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged Intermittent Renal Replacement Therapy for Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome.
    Ramirez-Sandoval JC; Gaytan-Arocha JE; Xolalpa-Chávez P; Mejia-Vilet JM; Arvizu-Hernandez M; Rivero-Sigarroa E; Torruco-Sotelo C; Correa-Rotter R; Vega-Vega O
    Blood Purif; 2021; 50(3):355-363. PubMed ID: 33105136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of extracorporeal carbon dioxide removal combined with continuous blood purification therapy in ARDS with hypercapnia in patients with critical COVID-19.
    Chen Y; Wang S; Huang J; Fu Y; Wen J; Zhou C; Fu Y; Liu L
    Clin Hemorheol Microcirc; 2021; 78(2):199-207. PubMed ID: 33554895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia.
    Phillips L; Pavisic J; Kaur D; Dorrello NV; Broglie L; Hijiya N
    Blood Adv; 2020 Sep; 4(18):4358-4361. PubMed ID: 32926122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Combined Extracorporeal CO2 Removal and Renal Replacement Therapy in Patients With Acute Respiratory Distress Syndrome and Acute Kidney Injury: The Pulmonary and Renal Support in Acute Respiratory Distress Syndrome Study.
    Allardet-Servent J; Castanier M; Signouret T; Soundaravelou R; Lepidi A; Seghboyan JM
    Crit Care Med; 2015 Dec; 43(12):2570-81. PubMed ID: 26488219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.
    Sukhdeo S; Negroponte E; Rajasekhar H; Gaur S; Horton DB; Malhotra A; Moorthy LN
    Lupus; 2021 Apr; 30(5):836-839. PubMed ID: 33509065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab for the Treatment of COVID-19-Induced Cytokine Storm and Acute Respiratory Distress Syndrome: A Case Series From a Rural Level 1 Trauma Center in Western Pennsylvania.
    Suresh K; Figart M; Formeck S; Mehmood T; Abdel Salam M; Bassilly D
    J Investig Med High Impact Case Rep; 2021; 9():23247096211019557. PubMed ID: 34105382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemofiltration as an Alternative for IL-6 Inhibitors in COVID-19 Cytokines Storm Associated with Underlaying Bacterial Infections: A Review Article.
    Zaky S; Elbadry M; Makhlouf HA; Abd-Elsalam S; Sarhan TS; Eltaweel NH; Aly H; Abdelbary A; Said A; Farouk MH; Abdel Baki A; Fathelbab H; Hammad R; El-Raey F
    Infect Disord Drug Targets; 2023; 23(6):e020523216437. PubMed ID: 37138434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of acute respiratory distress syndrome.
    Fernando SM; Ferreyro BL; Urner M; Munshi L; Fan E
    CMAJ; 2021 May; 193(21):E761-E768. PubMed ID: 34035056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.